{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:01:04Z","timestamp":1760983264048},"reference-count":170,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":4923,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1996,3,4]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold> Antisense oligonucleotides designed to complement a region of a particuler messenger RNA may inhibit gene expression potentially through sequence\u2010specific hybridization. Their inhibiting effect has been shown in a variety of in vitro and in vivo models in oncology, whereas much rarer clinical trials have been carried out. Rigorous demonstration of in vitro and in vivo specific effects upon their targets is mandatory before their use as drugs in cancer therapy.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1996.tb00153.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:22:31Z","timestamp":1251307351000},"page":"97-115","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recent status of the antisense oligonucleotide approaches in oncology"],"prefix":"10.1111","volume":"10","author":[{"given":"L.","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"issue":"1","key":"e_1_2_1_2_1","first-page":"374a","article-title":"Effectiveness of bcl\u20102 antisense oligodeoxynucleotides (AS\u2010ODN) against human follicular small\u2010cleaved cell lymphoma (FSCCL)\u2010 SCID mice xenograft model","volume":"84","author":"Abubakr YA","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_3_1","first-page":"4940","article-title":"Inhibition of cyclic AMP\u2010 triggered aromatase gene expression in human choriocarcinoma cells by antisense oligodeoxynucleotide","volume":"54","author":"Ackermann K.","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1992.2.261"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1993.1152"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.20.4670"},{"issue":"1","key":"e_1_2_1_7_1","first-page":"43a","article-title":"In vivo treatment of multidrug\u2010resistant murine leukemia with antisense MDRI oligodeoxynucleotides","volume":"84","author":"Azuma E.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116839"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900120103"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1992.2.109"},{"key":"e_1_2_1_11_1","first-page":"593","article-title":"Human studies using antisense against p53 in AML","volume":"34","author":"Bayever E.","year":"1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1993.3.383"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1688"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199310000-00018"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.15.3202"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.11.2150"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.15.3567"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1499"},{"key":"e_1_2_1_19_1","first-page":"1840","article-title":"The abnormal p53 protein expressed in CML cell lines are non\u2010functional","volume":"7","author":"Bi S.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_1_20_1","first-page":"582","article-title":"The involvement of \u201ctumor suppressor\u201d p53 in normal and chronic myelogenous leukemia hemopoiesis","volume":"54","author":"Bi S.","year":"1994","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_2_1_21_1","first-page":"443a","article-title":"Phase I trial of systemic administration of OL(1)p53 oligonucleotide in refractory acute myelogenous leukemia and advanced myelodysplastic syndrome","volume":"82","author":"Bishop MR","year":"1993","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_22_1","first-page":"740a","article-title":"Purging of peripheral blood progenitor cells with antisense oligonucleotide directed against bcr\u2010abl for chronic myelogenous leukemia","volume":"84","author":"Bishop MR","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_23_1","first-page":"189","article-title":"Experimental gene therapy of human colon cancer","volume":"116","author":"Bold RJ","year":"1994","journal-title":"Surgery"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5728"},{"key":"e_1_2_1_25_1","first-page":"367","article-title":"Raf\u20101 is a necessary component of the mitogenic response of the human megakaryoblastic leukemia cell line M07 to human stem cell factor, granulocyte\u2010macrophage colony\u2010stimulating factor, interleukin 3, and interleukin 9","volume":"5","author":"Brennscheidt U.","year":"1994","journal-title":"Cell Growth Differ"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","article-title":"Effects of phosphorothioate modification of oligonucleotides on specific protein binding","volume":"269","author":"Brown DA","year":"1994","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_2_1_27_1","first-page":"328a","article-title":"Partial inhibition of the megakaryocyte\u2010colony stimulating activity of human interleukin\u20103 by antisense oligonucleotides to the protooncogene c\u2010mpl","volume":"84","author":"Bruno E.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(93)90033-N"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood.V84.2.595.595","article-title":"Effects of bcl\u20102 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells","volume":"84","author":"Campos L.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.164"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(93)90010-B"},{"key":"e_1_2_1_32_1","first-page":"291","article-title":"Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides","volume":"9","author":"Ciardiello F.","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.84"},{"issue":"1","key":"e_1_2_1_34_1","first-page":"156a","article-title":"Optimisation of antisense oligodeoxynucleotide structure for targeting chronic myeloid leukemia (CML)","volume":"84","author":"Clark RE","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.405"},{"key":"e_1_2_1_36_1","first-page":"3049","article-title":"Antisense oligonucleotides suppress B\u2010cell lymphoma growth in a SCID\u2010hu mouse model","volume":"9","author":"Cotter FE","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90458-8"},{"key":"e_1_2_1_38_1","first-page":"261","article-title":"Elimination of clonogenic Philadelphia\u2010positive cells using bcr\u2010abl antisense oligodeoxynucleotides","volume":"12","author":"Fabritiis P.","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_39_1","first-page":"826","article-title":"Human Philadelphia chromosome\u2010positive chronic myeloid leukemia: a potential model for antisense therapy","volume":"21","author":"Lord C.","year":"1993","journal-title":"Exp Hematol"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.24.11762"},{"key":"e_1_2_1_41_1","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1016\/S0021-9258(17)34023-1","article-title":"Inhibition of protein kinase C\u2010\u03b1 expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM\u20101) mRNA by phorbol esters","volume":"269","author":"Dean NM","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_1_42_1","first-page":"1723","article-title":"Inhibition of Friend cells proliferation by spi\u20101 antisense oligodeoxynucleotides","volume":"9","author":"Delgado MD","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/ssu.2980100204"},{"key":"e_1_2_1_44_1","first-page":"1054","article-title":"Noninvasive imaging of c\u2010myc oncogene messenger RNA with indium\u2010111\u2010antisense probes in a mammary tumor\u2010 bearing mouse model","volume":"35","author":"Dewanjee MK","year":"1994","journal-title":"J Nucl Med"},{"key":"e_1_2_1_45_1","first-page":"844","article-title":"Kinetics of hybridization of mRNA of c\u2010myc oncogene with 111In\u2010labeled antisense oligodeoxynucleotide probes by high\u2010pressure liquid chromatography","volume":"16","author":"Dewanjee MK","year":"1994","journal-title":"Biotechniques"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117521"},{"issue":"1","key":"e_1_2_1_47_1","first-page":"S91","article-title":"Antiapoptotic effect of c\u2010fes protooncogene during granulocytic differentiation","volume":"8","author":"Ferrari S.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.1.221"},{"key":"e_1_2_1_49_1","first-page":"1859","article-title":"Effect of nucleolar p120 expression level on the proliferation capacity of breast cancer cells","volume":"54","author":"Fonagy A.","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V84.6.1881.1881","article-title":"Role for low\u2010 affinity receptor for IgE (CD23) in normal and leukemic B\u2010 cell proliferation","volume":"84","author":"Fournier S.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_51_1","first-page":"405","article-title":"Specific role for protein kinase C \u03b2 in cell differentiation","volume":"5","author":"Gamard CJ","year":"1994","journal-title":"Cell Growth Differ"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)90418-9"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309047876"},{"key":"e_1_2_1_54_1","first-page":"595","article-title":"Therapeutic applications of antisense DNA in the treatment of human leukemia","volume":"34","author":"Gewirtz AM.","year":"1993","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)90405-7"},{"key":"e_1_2_1_56_1","first-page":"577","article-title":"Antisense DNA inhibition of tumor growth induced by c\u2010Ha\u2010ras oncogene in nude mice","volume":"53","author":"Gray GD","year":"1993","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_2_1_57_1","first-page":"607a","article-title":"An antisense oligonucleotide to the transferrin receptor inhibits proliferation of leukemic cells in vitro","volume":"84","author":"Guimaraes JETE","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.6.2620"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.21.9901"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.10.4499"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb18462.x"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.78.6.0944"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.14.9.5661"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1994.tb03405.x"},{"issue":"1","key":"e_1_2_1_65_1","first-page":"39a","article-title":"Antisense oligonucleotides inhibit expression of human multidrug\u2010resistance (MDR1) gene dramatically increase in vitro chemosensitivity of human multiple myeloma cells","volume":"84","author":"Kay HD","year":"1994","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_66_1","first-page":"142a","article-title":"Inhibition of bcl\u20102 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to cytosine arabinoside","volume":"84","author":"Keith FJ","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_67_1","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.4049\/jimmunol.152.9.4328","article-title":"Up\u2010regulation of c\u2010myc induces the gene expression of the murine homologues of p34cdc2 and cyclin\u2010dependent kinase\u20102 in T lymphocytes","volume":"152","author":"Kim YH","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91438-R"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1993.3.157"},{"key":"e_1_2_1_70_1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood.V82.4.1142.bloodjournal8241142","article-title":"Regulation of manganeses superoxide dismutase and other antioxidant genes in normal and leukemic hematopoietic cells and their relationship to cytotoxicity by tumor necrosis factor","volume":"82","author":"Kizaki M.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8094261"},{"key":"e_1_2_1_72_1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood.V81.4.889.889","article-title":"Interleukin\u201011 acts as an autocrine growth factor for human megakaryoblastic cell lines","volume":"81","author":"Kobayashi S.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.123"},{"key":"e_1_2_1_74_1","first-page":"455","article-title":"Transforming activity of a newly cloned androgeninduced growth factor","volume":"9","author":"Kouhara H.","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/374546a0"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc00019a013"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1992.tb02734.x"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309047877"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.9.3860"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.17.7942"},{"key":"e_1_2_1_81_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4049\/jimmunol.150.2.399","article-title":"Endogenous secretion of IL\u20104 maintains growth and Thy\u20101 expression of a transformed B cell clone","volume":"150","author":"Louie SW","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.120.5.1281"},{"issue":"1","key":"e_1_2_1_83_1","first-page":"126a","article-title":"Autografting for chronic myelogenous leukemia (CML) with c\u2010myb antisense oligodeoxynucleotide purged bone marrow","volume":"84","author":"Luger SM","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1994.1195"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/5.suppl_1.S67"},{"issue":"1","key":"e_1_2_1_86_1","first-page":"21a","article-title":"In vitro treatment with p53 and\/or RB antisense (AS) oligodeoxynucleotides in association with growth factors (GF) induces proliferation of normal peripheral blood stem cells","volume":"84","author":"Mahdi T.","year":"1994","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_87_1","first-page":"138a","article-title":"Combined bcr\/abl abrogation by antisense (AS) oligonucleotides and transfection by the wild type (wt) P53 gene induce apoptosis in K562 cells","volume":"84","author":"Mahdi T.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90336-F"},{"issue":"1","key":"e_1_2_1_89_1","first-page":"633a","article-title":"Advantage of efficiency of oligomers antisense B2A2 in chronic myeloid leukemia","volume":"84","author":"Mahon FX","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7914032"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.5.1179.1179"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1993.3.309"},{"key":"e_1_2_1_93_1","first-page":"3988","article-title":"CD44 mediates human glioma cell adhesion and invasion in vitro","volume":"54","author":"Merzak A.","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.5.1395.1395"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1994.1253"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2996-5_21"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941101)74:9<2546::AID-CNCR2820740924>3.0.CO;2-Y"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)85268-7"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490340503"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1993.tb02723.x"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.23.5004"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-528"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90660-I"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199402000-00014"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.14.2830"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.7.2790"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(94)90476-6"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1993.tb05767.x"},{"key":"e_1_2_1_109_1","first-page":"985","article-title":"c\u2010fos expression is required during all phases of the cell cycle during exponential cell proliferation","volume":"14","author":"Pai SR","year":"1994","journal-title":"Anticancer Res"},{"issue":"1","key":"e_1_2_1_110_1","first-page":"574a","article-title":"Antisense acetylcholinesterase oligonucleotide promotes stem cell expansion and suppresses hematopoietic apoptosis","volume":"84","author":"Patinkin D.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.14.8.5326"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.13.5957"},{"key":"e_1_2_1_113_1","first-page":"3","article-title":"Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression","volume":"8","author":"Perlaky L.","year":"1993","journal-title":"Anticancer Drug Des"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(93)90054-D"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1677\/jme.0.0120127"},{"key":"e_1_2_1_116_1","first-page":"237","article-title":"Applications of antisense oligonucleotides in oncology","volume":"40","author":"Pierga JY","year":"1994","journal-title":"Cell Mol Biol"},{"key":"e_1_2_1_117_1","first-page":"1102","article-title":"Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin\u2010like growth factor 1","volume":"53","author":"Pietrzkowski Z.","year":"1993","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_2_1_118_1","first-page":"200a","article-title":"In vivo suppression of B\u2010cell lymphoma with bcl\u20102 antisense oligonucleotides","volume":"82","author":"Pocock C.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_119_1","doi-asserted-by":"crossref","first-page":"24564","DOI":"10.1016\/S0021-9258(17)31429-1","article-title":"Characterization of the oligonucleotide\u2010mediated inhibition of interferon\u2010\u03b3\u2010induced major histocompatibility complex class I and intercellular adhesion molecule\u20101","volume":"269","author":"Ramanathan M.","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090522"},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(05)80291-6"},{"key":"e_1_2_1_122_1","first-page":"262","article-title":"Inhibition of hepatitis B virus surface gene expression by antisense oligodeoxynucleotides in a human hepatoma cell line","volume":"39","author":"Reinis M.","year":"1992","journal-title":"Folia Biol"},{"key":"e_1_2_1_123_1","first-page":"756","article-title":"Insulin\u2010like growth factor\u20101 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines","volume":"69","author":"Resnicoff M.","year":"1993","journal-title":"Lab Invest"},{"key":"e_1_2_1_124_1","first-page":"2218","article-title":"Rat glioblastoma cells expressing an antisense to the insulin\u2010like growth factor\u20101 (IGF\u20101) receptor are nontumorigenic and induce regression of wild\u2010type tumors","volume":"54","author":"Resnicoff M.","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_125_1","first-page":"593","article-title":"Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells","volume":"22","author":"Roger SY","year":"1994","journal-title":"Exp Hematol"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-9084(93)90028-Q"},{"issue":"1","key":"e_1_2_1_127_1","first-page":"125a","article-title":"Oligodeoxynucleotides antisense to c\u2010abl specifically inhibit entry into S phase of CD34\u2010 positive hematopoietic cells and their differentiation to granulocyte\u2010macrophage progenitors","volume":"84","author":"Rosti V.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_128_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199304000-00011"},{"key":"e_1_2_1_129_1","first-page":"283","article-title":"Cellular pharmacology of p120 antisense oligodeoxynucleotide phosphorothioate ISIS 3466","volume":"5","author":"Saijo Y.","year":"1993","journal-title":"Oncol Res"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.449"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.3.749"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420115"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.5.2667"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.4048"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.3.513"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.22.10460"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490360108"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.6.1923"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116549"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.6.1855"},{"issue":"1","key":"e_1_2_1_141_1","first-page":"514a","article-title":"Human leukemia treatment in SCID mice by antisense oligodeoxynucleotides targeting cooperating oncogenes","volume":"84","author":"Skorski T.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.10.4504"},{"key":"e_1_2_1_143_1","first-page":"129","article-title":"Antisense bcr\u2010abl oligonucleotides induce apoptosis in the Philadelphia chromosome\u2010positive cell line BV173","volume":"8","author":"Smetsers TFCM","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_1_144_1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood.V82.2.625.625","article-title":"Antisense oligonucleotides to the p65 subunit of NF\u2010\u03baB block CD11b expression and alter adhesion properties of differentiated HL\u201060 granulocytes","volume":"82","author":"Sokoloski JA","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_145_1","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V84.6.1950.1950","article-title":"Transforming growth factor\u2010\u03b2 relieves stem cell factor\u2010 induced proliferation of myelogenous leukemia cells through inhibition of binding of the transcription factor NF\u2010 jun","volume":"84","author":"Sott C.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1716"},{"key":"e_1_2_1_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(94)90408-1"},{"key":"e_1_2_1_148_1","first-page":"2330","article-title":"Effects of human papillomavirus type 18\u2010specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines","volume":"53","author":"Steele C.","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8351515"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1994.4.67"},{"key":"e_1_2_1_151_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3535"},{"key":"e_1_2_1_152_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.125.6.1371"},{"key":"e_1_2_1_153_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.11.2729"},{"key":"e_1_2_1_154_1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood.V84.2.601.601","article-title":"Liposomal delivery of methylphosphonate antisense oligodeoxy\u2010 nucleotides in chronic myelogenous leukemia","volume":"84","author":"Tari AM","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.1686"},{"key":"e_1_2_1_156_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.1142"},{"key":"e_1_2_1_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(94)90075-2"},{"key":"e_1_2_1_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)46845-1"},{"key":"e_1_2_1_159_1","doi-asserted-by":"publisher","DOI":"10.1038\/372333a0"},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1993.1077"},{"key":"e_1_2_1_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)90170-8"},{"key":"e_1_2_1_162_1","doi-asserted-by":"publisher","DOI":"10.1089\/ard.1994.4.119"},{"key":"e_1_2_1_163_1","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.4049\/jimmunol.150.12.5614","article-title":"Molecular, biochemical, and functional characteristics of tumor necrosis factor\u2010\u03b1 produced by human placental cytotrophoblastic cells","volume":"150","author":"Yang Y.","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_1_164_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.17.7946"},{"key":"e_1_2_1_165_1","first-page":"868","article-title":"An antisense oligodeoxynucleotide that depletes RI\u03b1 subunit of cyclic AMP\u2010 dependent protein kinase induces growth inhibition in human cancer cells","volume":"53","author":"Yokozaki H.","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_166_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.20.4307"},{"key":"e_1_2_1_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(94)90090-6"},{"key":"e_1_2_1_168_1","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood.V84.11.3660.bloodjournal84113660","article-title":"Stage\u2010specific oligonucleotide uptake in murine bone marrow B\u2010cell precursors","volume":"84","author":"Zhao QY","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)02177-9"},{"key":"e_1_2_1_170_1","first-page":"5783","article-title":"Discovery of short, 3\u2032\u2010cholesterol\u2010modified DNA duplexes with unique antitumor cell activity","volume":"54","author":"Zhou JH","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.85"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1996.tb00153.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1996.tb00153.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T22:25:40Z","timestamp":1698359140000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1996.tb00153.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3,4]]},"references-count":170,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,3,4]]}},"alternative-id":["10.1111\/j.1472-8206.1996.tb00153.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1996.tb00153.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3,4]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}